One of the most common questions we hear from health-tech founders is, “who are the good seed-stage health-tech investors?” We compiled a U.S. list here, but lots of founders have asked us to put together a list for Europe. So here it is…
We opened this list to all investors in Europe, and we’re now sharing in time for the Q4 fundraising sprint.
[If you’d like to submit your fund for future edits of this post, please do so here.]
The concentration of health specialists in Europe remains within pre-seed and seed, with a somewhat predictable bias to B2B software. Even with the entry of several later stage US funds to Europe in recent years, the list of series A+ investment funds focusing on health remains short. So feels a pertinent time to refresh memories of our O.V. cheque size (€5-€20m), and Series A-B focus in Europe.
We had many submissions from some excellent generalist investors, but we’…